Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Global. It is testing Licarbazepine 750-2000 mg/d for manic episodes in bipolarity type I.
In Global
This study is completed in the United States. It is testing licarbazepine for manic episodes in bipolarity type I.
In CerritosThis study is enrolling by invitation in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.
Multiple locations, including ChinoThis study is completed in the United States. It focuses on schizophrenia.
In CatonsvilleThis study is completed in the United Kingdom, in Belgium, in Germany, .... It is testing intranasal Esketamine for treatment-resistant depression.
In GermanyThis study is enrolling by invitation in the United States. It is testing azetukalner for depression.
Multiple locations, including Little RockThis study is enrolling by invitation in the United States. It is testing azetukalner for depression.
Multiple locations, including PhoenixThis study is completed in the United States. It is testing naltrexone for ADHD.
In BostonThis study is completed in the United States. It is testing Long-term Safety, Tolerability, and Efficacy of KarXT for schizophrenia.
Multiple locations, including Little RockThis study was terminated in the United States. It is testing Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT for schizophrenia.
Multiple locations, including AtlantaThis study is completed in the United States. It focuses on PTSD.
In Omaha
This study was withdrawn in Global. It focuses on Addiction.
In GlobalHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.